MELTECH

Serial Number 79204741
602

Registration Progress

Application Filed
Nov 3, 2016
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

MELTECH

Basic Information

Serial Number
79204741
Filing Date
November 3, 2016
Abandonment Date
January 16, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 7, 2018
Classes
005

Rights Holder

Dexcel Pharma Technologies Ltd.

16
Address
21 Nahum Haftzadi St.
9123901 Jerusalem
IL

Ownership History

Dexcel Pharma Technologies Ltd.

Original Applicant
16
IL

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

25 events
Date Code Type Description Documents
Mar 10, 2023 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Mar 3, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 22, 2019 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 7, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 7, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 28, 2018 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Sep 12, 2018 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Sep 12, 2018 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 7, 2018 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 7, 2018 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jul 12, 2017 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 12, 2017 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 12, 2017 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 21, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 21, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 21, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 5, 2017 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 20, 2017 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 20, 2017 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 18, 2017 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 17, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 15, 2017 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 11, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 11, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 6, 2017 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005